RIA
XBI icon

Realta Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Realta Investment Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.1K Hold
588
– – 0.03% 242
2026
Q1 		$75.1K Hold
588
– – 0.03% 240
2025
Q4 		$71.7K Hold
588
– – 0.02% 234
2025
Q3 		$58.9K Buy
588
+74
+14% +$6.67K 0.02% 232
2025
Q2 		$42.6K Sell
514
-74
-13% -$5.9K 0.02% 237
2025
Q1 		$47.7K Hold
588
– – 0.02% 235
2024
Q4 		$54.3K Sell
588
-51
-8% -$4.94K 0.02% 247
2024
Q3 		$63.3K Sell
639
-3,488
-85% -$343K 0.03% 232
2024
Q2 		$383K Sell
4,127
-810
-16% -$72.6K 0.07% 272
2024
Q1 		$469K Sell
4,937
-330
-6% -$30.6K 0.1% 244
2023
Q4 		$470K Sell
5,267
-840
-14% -$62.4K 0.11% 227
2023
Q3 		$508K Buy
6,107
+100
+2% +$7.99K 0.12% 206
2023
Q2 		$500K Sell
6,007
-210
-3% -$17.6K 0.11% 222
2023
Q1 		$474K Sell
6,217
-2,255
-27% -$187K 0.12% 213
2022
Q4 		$703K Hold
8,472
– – 0.17% 139
2022
Q3 		$672K Sell
8,472
-963
-10% -$81.2K 0.18% 146
2022
Q2 		$722K Buy
9,435
+58
+0.6% +$4.35K 0.18% 133
2022
Q1 		$843K Buy
9,377
+4,245
+83% +$392K 0.17% 134
2021
Q4 		$575K Buy
5,132
+230
+5% +$27.7K 0.13% 190
2021
Q3 		$616K Buy
4,902
+50
+1% +$6.44K 0.15% 176
2021
Q2 		$657K Sell
4,852
-40
-0.8% -$5.26K 0.16% 164
2021
Q1 		$664K Buy
4,892
+21
+0.4% +$3.14K 0.17% 151
2020
Q4 		$686K Buy
4,871
+6
+0.1% +$769 0.19% 121
2020
Q3 		$542K Sell
4,865
-135
-3% -$15.1K 0.18% 144
2020
Q2 		$560K Buy
5,000
+275
+6% +$27.1K 0.18% 139
2020
Q1 		$366K Buy
4,725
+641
+16% +$56.8K 0.16% 177
2019
Q4 		$383K Buy
4,084
+373
+10% +$32.3K 0.1% 224
2019
Q3 		$286K Buy
3,711
+470
+15% +$39.1K 0.08% 265
2019
Q2 		$286K Buy
3,241
+1,229
+61% +$105K 0.08% 265
2019
Q1 		$185K Buy
+2,012
New +$171K 0.08% 283

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Realta Investment Advisors's XBI Position: Q2 2026 in Review

Realta Investment Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 588 shares worth $93.1K. The position accounts for 0.03% of the portfolio, ranked #242.

Realta Investment Advisors first reported a position in XBI in Q1 2019 and has held it in 30 quarters since. The position peaked at $843K in Q1 2022. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Realta Investment Advisors held 588 shares of State Street SPDR S&P Biotech ETF worth $93.1K as of Q2 2026.
  • Realta Investment Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.03% of Realta Investment Advisors's portfolio in Q2 2026, its #242 holding.
  • Realta Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and has held it in 30 quarters since.
  • Realta Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $843K in Q1 2022.
  • 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Realta Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.